Ga. Brazeau et al., IN-VITRO MYOTOXICITY OF SELECTED CATIONIC MACROMOLECULES USED IN NONVIRAL GENE DELIVERY, Pharmaceutical research, 15(5), 1998, pp. 680-684
Purpose. Cationic lipid/DNA complexes have been proposed as a method o
f in vivo gene delivery via intravenous or intramuscular injection. A
concern with using these polycationic molecules is whether they are as
sociated with tissue toxicity at the injection site. Therefore, the ob
jective of these studies was to investigate the myotoxic potential of
selected non-viral gene delivery macromolecules (e.g., cationic lipids
and polymers) with and without plasmid DNA (pDNA) in vitro. Methods.
Myotoxicity was assessed by the cumulative release of creatine kinase
(CK) over 90 minutes from the isolated rodent extensor digitorum longu
s muscle into a carbogenated balanced salt solution (BBS, pH 7.4, 37 d
egrees C) following a 15 mu L injection of the test formulation. Pheny
toin (Dilantin(R)) and normal saline served as positive and negative c
ontrols, respectively. Results. The myotoxicity of plasmid DNA (pDNA,
similar to 5000bp, 1 mg/ml) was not statistically different from norma
l saline. However, the myotoxicity of Dilantin(R) was 16-times higher
than either normal saline or pDNA (p < 0.05). Cationic liposomes were
found to be less myotoxic than polylysine and PAMAM dendrimers. Polyly
sine's myotoxicity was found to be dependent upon concentration and mo
lecular weight. The myotoxicity of formulations of cationic liposomes(
s), lower molecular weight polylysine (25,000) and higher concentratio
n of PAMAM dendrimers with pDNA were found to be statistically less si
gnificant than those formulations without pDNA. Conclusions. The catio
nic liposomes were less myotoxic compared to the dendrimers and polyly
sine. Myotoxicity was dependent upon the type of cationic lipid macrom
olecule, concentration, molecular weight and the presence of pDNA. A p
ossible explanation for this reduced tissue damage in cationic lipids
complexed with pDNA is that the formation of complex reduces the overa
ll positive charge of the injectable system resulting in less damage.